RSK2 Antibody [Alexa Fluor™ Plus 555]

• Reactivity: Hu, Mu
• Applications: WB, IHC, IP, IP (-)
• Clonality: Polyclonal
• Host: Rabbit
• Conjugate: Alexa Fluor Plus 555

RSK2 Antibody [Alexa Fluor™ Plus 555] Summary

• Immunogen: maps to a region between residue 1 and 50 of human ribosomal S6 kinase 2 using the numbering given in entry NP_004577.1
• Isotype: IgG
• Clonality: Polyclonal
• Host: Rabbit
• Gene: RPS6KA3
• Purity: Immunogen affinity purified

Applications/Dilutions

• Dilutions:
  • Immunohistochemistry
  • Immunoprecipitation
  • Western Blot
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide
• Purity: Immunogen affinity purified

Notes

This product is provided under an intellectual property license from Life Technologies Corporation. The transfer of this product is conditioned on the buyer using the purchased product solely in research conducted by the buyer, excluding contract research or any fee for service research, and the buyer must not (1) use this product or its components for (a) diagnostic, therapeutic or prophylactic purposes; (b) testing, analysis or screening services, or information in return for compensation on a per-test basis; or (c) manufacturing or quality assurance or quality control, and/or (2) sell or transfer this product or its components for resale, whether or not resold for use in research. For information on purchasing a license to this product for purposes other than as described above, contact Life Technologies Corporation, 5781 Van Allen Way, Carlsbad, CA 92008 USA or outlicensing@thermofisher.com. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.

Alternate Names for RSK2 Antibody [Alexa Fluor™ Plus 555]

• 90 kDa ribosomal protein S6 kinase 3
• CLS
• Coffin-Lowry syndrome
• EC 2.7.11
• EC 2.7.11.1
• HU-3
• Insulin-stimulated protein kinase 1
• ISPK1
• ISPK-1
• MAP kinase-activated protein kinase 1b
• MAPK-activated protein kinase 1b
• MAPKAP kinase 1b
• MAPKAPK1B
• MAPKAPK-1b
• mental retardation, X-linked 19
• MRX19
• p90-RSK2
• p90RSK3
• pp90RSK2
• ribosomal protein S6 kinase alpha-3
• ribosomal protein S6 kinase, 90kD, polypeptide 3
• ribosomal protein S6 kinase, 90kDa, polypeptide 3
• Ribosomal S6 kinase 2
• RPS6KA3
• RSK
• RSK2
• RSK-2
• RSK2p90-RSK 3
• S6K-alpha3
• S6K-alpha-3

Background

Ribosomal protein S6 kinase II (RSK2) is a protein serine/threonine kinase that was originally detected by its ability to catalyze the multi-site phosphorylation of the 40S ribosomal protein S6 in vitro. One of the important substrates of RSK may be the Glycogenbinding subunit of Protein phosphatase-1, which when phosphorylated by RSK, appears to activate Protein phosphatase 1. This results in increased dephosphorylation and activation of Glycogen synthase to enhance Glycogen synthesis.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: RPS6KA3